Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| HTH-01-091 | C26H28Cl2N4O2 | 2000209-42-5 | Details |
| Bersanlimab | 1987854-08-9 | Details |
| Etokimab | 2022981-44-6 | Details |
| L-Clausenamide | C18H19NO3 | 201529-58-0 | Details |
| Tiragolumab | 1918185-84-8 | Details |
| Toripalimab | 1924598-82-2 | Details |
| ASK120067 | C29H32ClN7O2 | 1934259-00-3 | Details |
| Q134R | C22H17F3N4O | 2022949-46-6 | Details |
| (S,R,S)-AHPC-C1-NH2 | C24H33N5O4S | 2010986-20-4 | Details |
| Vocacapsaicin hydrochloride | C26H42ClN3O4 | 1931116-92-5 | Details |
| DSM421 | C14H11F5N6 | 2011769-21-2 | Details |
| CRK12-IN-2 | C23H33F2N5O3S2 | 1990479-17-8 | Details |
| MJN68390 | 1956368-39-0 | Details |
| Elarofiban | C22H32N4O4 | 198958-88-2 | Details |
| GSK8814 | C28H35F2N5O3 | 1997369-78-4 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| LYPLAL1-IN-1 | C29H29N7O4 | 1966129-74-7 | Details |
| Parsaclisib hydrochloride | C20H23Cl2FN6O2 | 1995889-48-9 | Details |
| IRAK4-IN-20 | C22H25F3N4O3 | 1931994-80-7 | Details |
| Avotaciclib | C13H11N7O | 1983983-41-0 | Details |
| Dihydrocelastrol | C29H40O4 | 193957-88-9 | Details |
| Mitiperstat | C15H15ClN4OS | 1933460-19-5 | Details |
| Bomedemstat ditosylate | C35H42FN7O5S | 1990504-72-7 | Details |
| Minretumomab | 195189-17-4 | Details |
| Norethindrone (Ethynyl-13C2) | 201741-02-8 | Details |
| AS-601811 | C15H17NO | 194979-95-8 | Details |
| Vepalimomab | 195158-85-1 | Details |
| Prasinezumab | 1960462-19-4 | Details |
| Marstacimab | 1985638-39-8 | Details |
| PDD00017238 | C19H20N6O3S3 | 1952247-05-0 | Details |
| Perphenazine dihydrochloride | C21H28Cl3N3OS | 2015-28-3 | Details |
| DDX3-IN-2 | C20H23N5O | 1919828-81-1 | Details |
| S1R agonist 1 | C20H25NO | 193354-70-0 | Details |
| HNPMI | C22H20N2O3 | 1980848-48-3 | Details |
| ZEN-3411 | C21H20N4O2 | 1952264-36-6 | Details |
| Spartalizumab | 1935694-88-4 | Details |
| Dostarlimab | 2022215-59-2 | Details |
| Cobolimab | 2022215-65-0 | Details |
| Gnetifolin K | C27H34O14 | 193806-40-5 | Details |
| Ochratoxin α | C11H9ClO5 | 19165-63-0 | Details |
| Elarofiban TFA | 198958-89-3 | Details |
| (Rac)-GSK 372475 | 195875-98-0 | Details |
| Bedoradrine sulfate | C24H34N2O9S | 194785-31-4 | Details |
| Farglitazar | C34H30N2O5 | 196808-45-4 | Details |
| Ianalumab | 1929549-92-7 | Details |
| Atidortoxumab | 1939108-95-8 | Details |
| Onvatilimab | 1969313-51-6 | Details |
| Antiproliferative agent-36 | C13H11N5S | 193828-76-1 | Details |
| Anetumab | 1954758-84-9 | Details |
| Selvigaltin | C19H16BrF3N4O4S | 1978336-95-6 | Details |
| ZINC194100678 | C10H13N5O | 1995025-05-2 | Details |
| Desthiobiotin-PEG4-propargyl | C21H37N3O6 | 1951424-89-7 | Details |
| (7R)-Methoxy-8-epi-matairesinol | C21H24O7 | 198827-23-5 | Details |
| Thalidomide-O-amido-PEG-C2-NH2 | C19H22N4O7 | 2022182-59-6 | Details |
| Olorofim | C28H27FN6O2 | 1928707-56-5 | Details |
| GNE-375 | C25H29N3O5 | 1926989-06-1 | Details |
| CFTR corrector 4 | C29H27F2NO7 | 1918142-34-3 | Details |
| Bemarituzumab | 1952272-74-0 | Details |
| Nirsevimab | 1989556-22-0 | Details |
| GW2974 | C23H21N7 | 202272-68-2 | Details |
| KCL-286 | C19H14N2O4 | 1952276-71-9 | Details |
| 7-Deoxynarciclasine | C14H13NO6 | 19622-83-4 | Details |
| ABH Hydrochloride | C6H15BClNO4 | 194656-75-2 | Details |
| Troriluzole | C15H16F3N5O4S | 1926203-09-9 | Details |
| ZEN-3219 | C19H18N2O3 | 1952264-34-4 | Details |
| Zagotenemab | 2019133-28-7 | Details |
| Hex | C5H10NO5P | 2004714-32-1 | Details |
| Itriglumide | C33H38N2O4 | 201605-51-8 | Details |
| SIB 1553A | C13H20ClNOS | 191611-76-4 | Details |
| Berlimatoxumab | 1939109-24-6 | Details |
| Crovalimab | 1917321-26-6 | Details |
| Puliginurad | C19H16N2O2S | 2013582-27-7 | Details |
| Etiprednol dicloacetate | C24H30Cl2O6 | 199331-40-3 | Details |
| JAK3i | C18H15FN4O3 | 1918238-72-8 | Details |
| KIRA-7 | C27H23FN6O | 1937235-76-1 | Details |
| Zenocutuzumab | 1969309-56-5 | Details |
| Imaprelimab | 2014343-04-3 | Details |
| Donanemab | 1931944-80-7 | Details |
| PDD00017272 | C23H25N5O4S3 | 1945950-20-8 | Details |
| JAK-IN-14 | C19H15FN4O | 1973485-06-1 | Details |
| ADT-007 | C26H24FNO5 | 1945941-09-2 | Details |
| CFTR corrector 8 | C29H27F2NO7 | 1918142-35-4 | Details |
| CRK12-IN-1 | C20H26F2N4O3S2 | 1990479-14-5 | Details |
| PI3Kδ/γ-IN-1 | C25H28N6O4S | 1980884-01-2 | Details |
| BMS-212122 | C43H36F6N4O2 | 194213-64-4 | Details |
| PQR514 | C16H20F2N8O2 | 1927857-55-3 | Details |
| Thalidomide-NH-(CH2)2-NH2 TFA | C17H17F3N4O6 | 1957235-67-4 | Details |
| Celosin K | C47H74O19 | 1950579-53-9 | Details |
| CCR4 antagonist 3-1 | C14H12N2S | 1957-01-3 | Details |
| BPN-15477 | C12H10ClN5 | 1971086-99-3 | Details |
| Bedoradrine | C24H32N2O5 | 194785-19-8 | Details |
| Filapixant | C24H26F3N5O3S | 1948232-63-0 | Details |
| Vancomycin monohydrochloride | C66H76Cl3N9O24 | 197638-25-8 | Details |
| (-)-OPC-51803 | C26H32ClN3O2 | 192514-57-1 | Details |
| R110 | C15H17ClN2OS | 1985622-33-0 | Details |
| CCG-257081 | C24H19ClF3N3O2 | 1922098-90-5 | Details |
| Aldumastat | C20H24F2N4O3 | 1957278-93-1 | Details |
| OPC-51803 | C26H32ClN3O2 | 192514-54-8 | Details |
| AChE/BuChE-IN-4 | C17H23N5 | 1997158-25-4 | Details |
| Product Total： Product Page： | ||||
| 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||